| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/02/1995 | DE4325465A1 Oral pharmaceutical preparation for the therapy of pain |
| 02/02/1995 | DE4325100A1 Highly fluorinated alkanes and medicinal applications |
| 02/02/1995 | DE4324884A1 Medicaments for external and systemic treatment of ornamental and useful [farmed] fish |
| 02/02/1995 | DE3348444C2 Analgesic and antiinflammatory compositions |
| 02/02/1995 | CA2472404A1 Combination of stent and anti-angiogenic factor |
| 02/02/1995 | CA2468375A1 Anti-angiogenic compositions, uses and methods |
| 02/02/1995 | CA2168096A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 02/02/1995 | CA2167843A1 Method of treating hiv with azaspiranes |
| 02/02/1995 | CA2167842A1 Method of inhibiting the replication of human immunodeficiency viruses with substituted azaspiranes |
| 02/02/1995 | CA2167841A1 Method of inhibiting the production of human immunodeficiency viruses with substituted azaspiranes |
| 02/02/1995 | CA2167837A1 Vitamin d analogues |
| 02/02/1995 | CA2167821A1 New silylated benzylamine derivatives and their salts; process for producing the same and pharmaceutical compositions containing them |
| 02/02/1995 | CA2167805A1 Methods of treating apoptosis and associated conditions |
| 02/02/1995 | CA2167537A1 Hepatitis c virus proliferation inhibitor |
| 02/02/1995 | CA2167529A1 Compositions and methods for reducing salmonella in chickens |
| 02/02/1995 | CA2167519A1 Method of treating alcohol dependency |
| 02/02/1995 | CA2167507A1 Benzo-fused lactams promote release of growth hormone |
| 02/02/1995 | CA2167410A1 Endothelin antagonists |
| 02/02/1995 | CA2167308A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
| 02/02/1995 | CA2167303A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | CA2167302A1 Oncoprotein protein kinase |
| 02/02/1995 | CA2166890A1 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 02/02/1995 | CA2165982A1 N,n,n-trimethylsphingosine derivatives |
| 02/02/1995 | CA2161538A1 Controlled release tacrine drug delivery systems and methods for preparing same |
| 02/02/1995 | CA2145067A1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals |
| 02/02/1995 | CA2144758A1 New n,n,n',n'-tetrasubstituted-1,2-ethanediamine derivative compounds |
| 02/02/1995 | CA2144521A1 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity |
| 02/01/1995 | EP0636693A2 Maltose-trehalose converting enzyme, and preparation and uses thereof |
| 02/01/1995 | EP0636632A2 Non-reducing oligosaccharides and their production and use |
| 02/01/1995 | EP0636631A1 Platinum complex and antineoplastic agent |
| 02/01/1995 | EP0636627A1 Cephem compounds and antimicrobial agents |
| 02/01/1995 | EP0636626A1 Pyrazolopyrimidine Derivatives |
| 02/01/1995 | EP0636625A2 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| 02/01/1995 | EP0636623A1 Indole derivatives as 5-HT1- like agonists |
| 02/01/1995 | EP0636619A1 Tricyclic heterocyclic compound |
| 02/01/1995 | EP0636618A1 Spontaneously dispersible concentrates and microemulsions with vitamin E compounds for the preparation of medicaments with anti-tumour activity |
| 02/01/1995 | EP0636614A1 Derivatives of 1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one, their preparation and pharmaceutical compositions containing them |
| 02/01/1995 | EP0636611A2 Optically active 1,4-dihydropyridine derivatives and process for preparing the same |
| 02/01/1995 | EP0636609A1 1-Benzyl-1,3-dihydro-indol-2-one derivatives, their preparation, the pharmaceutical compositions containing them |
| 02/01/1995 | EP0636608A1 Derivatives of 1-benzenesulfonyl-1,3-dihydro-indol-2-one, their preparation and pharmaceutical compositions containing them |
| 02/01/1995 | EP0636602A1 A process for the preparation of diacerein |
| 02/01/1995 | EP0636378A1 Absorbable composite materials for use in the treatment of periodontal disease |
| 02/01/1995 | EP0636374A2 A spermicidal anti-viral lubricant composition |
| 02/01/1995 | EP0636372A1 Antiviral, antitumor, antimetastatic, immune system enhancing 7-thia-guanosine derivatives |
| 02/01/1995 | EP0636371A1 Antitussive |
| 02/01/1995 | EP0636370A1 Sustained release compositions containing morphine |
| 02/01/1995 | EP0636369A1 Pyrimidones and imidazolinones for treatment of shock |
| 02/01/1995 | EP0636368A1 The use of 2- phenylmethylene -1- 3'-(amino)-2'-(hydroxy)--propoxy-imino -cyclohexane derivatives |
| 02/01/1995 | EP0636367A1 Use of phenylalkylamines for producing cholesterol lowering agents |
| 02/01/1995 | EP0636246A1 Method and kit for epithelial cancer screening |
| 02/01/1995 | EP0636138A1 Fluorinated 4-aminoandrostadienone derivatives and process for their preparation |
| 02/01/1995 | EP0636133A1 Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents |
| 02/01/1995 | EP0636132A1 Substituted nitrogen containing spiro compounds for use in treating cognitive deficits |
| 02/01/1995 | EP0636131A1 Heteroaromatic 5-hydroxytryptamine receptor agonists |
| 02/01/1995 | EP0636130A1 Azacyclic compounds |
| 02/01/1995 | EP0636129A1 Indole derivatives as 5-ht1-like agonists |
| 02/01/1995 | EP0636128A1 Piperazinocarbonylcarbostyrils as peripheral vasodilators |
| 02/01/1995 | EP0636127A1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 02/01/1995 | EP0636125A1 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 02/01/1995 | EP0636124A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives, preparation thereof and drugs containing same |
| 02/01/1995 | EP0636123A1 3-ureido substituted benzodiazepin-2-ones having cholecystokinin and/or gastrin antagonistic activity and their use in therapy |
| 02/01/1995 | EP0636119A1 Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase |
| 02/01/1995 | EP0636117A1 Use of pyruvamide and selected pyruvyl-amino acids |
| 02/01/1995 | EP0636028A1 Self-assembling polynucleotide delivery system |
| 02/01/1995 | EP0636027A1 Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy |
| 02/01/1995 | EP0636026A1 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor |
| 02/01/1995 | EP0636025A1 Compounds useful for treating allergic or inflammatory diseases |
| 02/01/1995 | EP0636024A1 Potentiation of antimicrobial effects |
| 02/01/1995 | EP0636023A1 Aminoguanidine spray drying process |
| 02/01/1995 | EP0636022A1 Chemical prevention or reversal of cataract by phase separation inhibitors |
| 02/01/1995 | EP0636021A1 Psychoactive propargylamine derivatives |
| 02/01/1995 | EP0636020A1 A pharmaceutical carrier system containing defined lipids |
| 02/01/1995 | EP0599987A4 Method for lowering blood lipid levels. |
| 02/01/1995 | EP0556308B1 Oxysulfonyl urea acat inhibitors |
| 02/01/1995 | EP0549594B1 (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same |
| 02/01/1995 | EP0528997B1 Disulfide derivatives of mercaptoacylamino acids |
| 02/01/1995 | EP0519950B1 Pharmaceutical composition |
| 02/01/1995 | EP0502110B1 (hetero) 4-arylmethoxy phenyl diazole derivatives, method for preparing same, and their therapeutical applications |
| 02/01/1995 | EP0495776B1 Stabilized nitric oxide-primary amine complexes useful as cardiovascular agents |
| 02/01/1995 | EP0486561B1 Buccal composition containing s(+) flurbiprofen or ketoprofen |
| 02/01/1995 | EP0469125B1 Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives |
| 02/01/1995 | EP0420877B1 A method and composition for preventing surgical adhesions |
| 02/01/1995 | EP0404797B1 1H/3H-[4-(N,N-CYCLOALKYL AND/OR BRANCHED-ALKYLCARBOXAMIDO) -BENZYL]IMIDAZO[4,5-c]PYRIDINES AS PAF ANTAGONISTS |
| 02/01/1995 | CN1098140A Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 02/01/1995 | CN1098107A Modified oligodeoxyribonucleotides, their preparation and their therapeutic use |
| 02/01/1995 | CN1098104A Carbapenem derivatives and their salts |
| 02/01/1995 | CN1098103A Novel pyridone carboxylic acid derivatives |
| 02/01/1995 | CN1098099A Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses |
| 02/01/1995 | CN1098098A 哌嗪衍生物 Piperazine derivatives |
| 02/01/1995 | CN1098095A Salt of (S)-a-phenyl-2-pyridineethanamine useful in therapy |
| 02/01/1995 | CN1098094A Aryl substituted heterocycles |
| 02/01/1995 | CN1098091A Arylalkylamide ethanesulfonic acid, and preparation and application thereof |
| 02/01/1995 | CN1097989A Cane sugar Fe, preparing process and preparation thereof |
| 02/01/1995 | CN1097988A Process for producing jiaoqijing for curing beriberi |
| 02/01/1995 | CN1097987A Transdermal hormone replacement therapy |
| 02/01/1995 | CN1097986A 复方利福平注射液 Compound rifampicin injection |
| 02/01/1995 | CN1097985A Soft viaminate capsule and producing process thereof |
| 02/01/1995 | CN1097984A Methods for administering biological agents and microparticle compositions useful in these and other methods |
| 02/01/1995 | CN1097982A Topical composition for inhibiting hair growth |
| 02/01/1995 | CN1097980A 壳聚糖明胶海绵 Chitosan gelatin sponge |